» Articles » PMID: 39053003

Perinatal Remote Blood Pressure Monitoring

Overview
Journal Obstet Gynecol
Date 2024 Jul 25
PMID 39053003
Authors
Affiliations
Soon will be listed here.
Abstract

Perinatal mortality and severe maternal morbidity among individuals with hypertensive disorders of pregnancy (HDP) are often driven by persistent, uncontrolled hypertension. Whereas traditional perinatal blood pressure (BP) ascertainment occurs through in-person clinic appointments, self-measured blood pressure (SMBP) programs allow individuals to measure their BP remotely and receive remote management by a medical team. Though data remain limited on clinically important outcomes such as maternal morbidity, these programs have shown promise in improving BP ascertainment rates in the immediate postpartum period and enhancing racial and ethnic equity in BP ascertainment after hospital discharge. In this narrative review, we provide an overview of perinatal SMBP programs that have been described in the literature and the data that support their efficacy. Furthermore, we offer suggestions for practitioners, institutions, and health systems that may be considering implementing SMBP programs, including important health equity concerns to be considered. Last, we discuss opportunities for ongoing and future research regarding SMBP programs' effects on maternal morbidity, long-term health outcomes, inequities that are known to exist in HDP and HDP-related outcomes, and the cost effectiveness of these programs.

References
1.
Niu B, Mukhtarova N, Alagoz O, Hoppe K . Cost-effectiveness of telehealth with remote patient monitoring for postpartum hypertension. J Matern Fetal Neonatal Med. 2021; 35(25):7555-7561. DOI: 10.1080/14767058.2021.1956456. View

2.
Parker S, Ajayi A, Yarrington C . De Novo Postpartum Hypertension: Incidence and Risk Factors at a Safety-Net Hospital. Hypertension. 2022; 80(2):279-287. DOI: 10.1161/HYPERTENSIONAHA.122.19275. View

3.
Ackerman-Banks C, Lipkind H, Palmsten K, Ahrens K . Association between hypertensive disorders of pregnancy and cardiovascular diseases within 24 months after delivery. Am J Obstet Gynecol. 2023; 229(1):65.e1-65.e15. PMC: 10330109. DOI: 10.1016/j.ajog.2023.04.006. View

4.
Hauspurg A, Jeyabalan A . Postpartum preeclampsia or eclampsia: defining its place and management among the hypertensive disorders of pregnancy. Am J Obstet Gynecol. 2022; 226(2S):S1211-S1221. PMC: 8857508. DOI: 10.1016/j.ajog.2020.10.027. View

5.
Janssen M, Demers S, Srinivas S, Bailey S, Boggess K, You W . Implementation of a text-based postpartum blood pressure monitoring program at 3 different academic sites. Am J Obstet Gynecol MFM. 2021; 3(6):100446. DOI: 10.1016/j.ajogmf.2021.100446. View